Stock Based Compensation - Theseus Pharmaceuticals Inc (NASDAQ:THRX) - Alpha Spread

Watchlist Manager

Watchlist

Price: 4.06 USD

Updated:

Theseus Pharmaceuticals Inc
Stock-Based Compensation

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Theseus Pharmaceuticals Inc
Stock-Based Compensation Peer Comparison

JNJ

BMY

PFE

MRK

LLY

Company		Stock-Based Compensation	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Theseus Pharmaceuticals Inc NASDAQ:THRX	Stock-Based Compensation $11.4m	CAGR 3-Years 229%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Johnson & Johnson NYSE:JNJ	Stock-Based Compensation $1.2B	CAGR 3-Years 3%	CAGR 5-Years 4%	CAGR 10-Years 5%
	Bristol-Myers Squibb Co NYSE:BMY	Stock-Based Compensation $529m	CAGR 3-Years -10%	CAGR 5-Years 19%	CAGR 10-Years 11%
	Pfizer Inc NYSE:PFE	Stock-Based Compensation $640m	CAGR 3-Years -10%	CAGR 5-Years -7%	CAGR 10-Years 3%
	Merck & Co Inc NYSE:MRK	Stock-Based Compensation N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Eli Lilly and Co NYSE:LLY	Stock-Based Compensation $656.7m	CAGR 3-Years 27%	CAGR 5-Years 18%	CAGR 10-Years 16%

See Also

Based on the financial report for Dec 31, 2022, Theseus Pharmaceuticals Inc's Stock-Based Compensation amounts to 11.4m USD.

Over the last year, the Stock-Based Compensation growth was 162%. The average annual Stock-Based Compensation growth rates for Theseus Pharmaceuticals Inc have been 229% over the past three years .

Join more than 143,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.